CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 64 filers reported holding CUE BIOPHARMA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,403 | -95.0% | 2,349 | -89.5% | 0.00% | – |
| Q1 2022 | $108,000 | -59.2% | 22,300 | -4.8% | 0.00% | – |
| Q4 2021 | $265,000 | -20.4% | 23,435 | +2.6% | 0.00% | – |
| Q3 2021 | $333,000 | -10.0% | 22,835 | -28.0% | 0.00% | – |
| Q2 2021 | $370,000 | +6.3% | 31,725 | +11.4% | 0.00% | – |
| Q1 2021 | $348,000 | -26.1% | 28,490 | -24.3% | 0.00% | – |
| Q4 2020 | $471,000 | +29.0% | 37,651 | +55.3% | 0.00% | – |
| Q3 2020 | $365,000 | -17.4% | 24,246 | +34.5% | 0.00% | – |
| Q2 2020 | $442,000 | +333.3% | 18,032 | +151.6% | 0.00% | – |
| Q1 2020 | $102,000 | -10.5% | 7,167 | -1.1% | 0.00% | – |
| Q4 2019 | $114,000 | +147.8% | 7,244 | +25.8% | 0.00% | – |
| Q3 2019 | $46,000 | -62.6% | 5,760 | -58.3% | 0.00% | – |
| Q2 2019 | $123,000 | -29.7% | 13,809 | -39.5% | 0.00% | – |
| Q1 2019 | $175,000 | +63.6% | 22,823 | -1.2% | 0.00% | – |
| Q4 2018 | $107,000 | -84.4% | 23,094 | -69.5% | 0.00% | – |
| Q3 2018 | $684,000 | -6.9% | 75,646 | +22.0% | 0.00% | – |
| Q2 2018 | $735,000 | +362.3% | 62,004 | +442.5% | 0.00% | – |
| Q1 2018 | $159,000 | – | 11,429 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 820,000 | $11,636,000 | 12.56% |
| Prosight Management, LP | 552,060 | $7,834,000 | 3.66% |
| Nantahala Capital Management | 2,503,840 | $35,529,000 | 1.33% |
| MANGROVE PARTNERS IM, LLC | 601,398 | $8,534,000 | 1.18% |
| Voss Capital, LLC | 88,670 | $749,000 | 1.00% |
| Slate Path Capital LP | 870,694 | $12,355,000 | 0.95% |
| Avoro Capital Advisors LLC | 1,870,000 | $26,535,000 | 0.90% |
| Bleichroeder LP | 165,000 | $2,341,000 | 0.61% |
| 683 Capital Management, LLC | 640,000 | $9,082,000 | 0.54% |
| PA Capital LLC | 40,706 | $578,000 | 0.51% |